Payer+Provider's Health System Review
November 1, 2023
The updated American Cancer Society guideline says former smokers should get annual CT scans long after they quit.
September 29, 2023
The Food and Drug Administration says some laboratory developed tests are unreliable and potentially hurt patients.
September 20, 2023
It would have been the first needle-free treatment for serious allergic reactions triggered by certain foods, insect stings and medications.
September 11, 2023
The new coronavirus shots are designed to provide improved protection against omicron subvariants now in circulation.
The covid vaccines are expected to be available later this week after the Centers for Disease Control and Prevention signs off.
August 8, 2023
The findings could increase demand for the drug and bolster the case for insurance coverage.
July 17, 2023
The findings increase the likelihood the medication will be the second treatment approved that alters the course of the disease.
July 13, 2023
The Food and Drug Administration’s approval of Opill comes six decades after birth control pills were introduced in the nation.
July 6, 2023
The medicine, called Leqembi, slowed decline by 27 percent over 18 months compared with placebo, a study showed. But side effects and cost are fueling controversy.
July 3, 2023
A drug called Leqembi, which modestly slows progression of the disease, is expected soon to receive full approval from federal regulators.